Search research articles
Contact Us
Filters
Showing results (61-70 of 224) with videos related to
Page
of 23
Sort By:
Haematologica
|
May 30, 2024
The phase III DUO trial of PI3K inhibitor duvelisib <i>versus</i> ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival
Alexey V Danilov, Ian W Flinn, Matthew S Davids, et al.
European Journal of Heart Failure
|
May 10, 2017
Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia
David D Berg, Muthiah Vaduganathan, Anju Nohria, et al.
Pharmacoeconomics - Open
|
September 30, 2020
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
Neerav Monga, Jamie Garside, Matthew S Davids, et al.
Advances in Hematology
|
December 29, 2025
Multiple Myeloma and Secondary Immunodeficiency: A Retrospective Database Analysis Assessing Burden of Infection and Treatment Patterns
Csaba Siffel, Matthew S Davids, Colin Anderson-Smits, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
Anuja Chatterjee, Sheila Shapouri, Beenish S Manzoor, et al.
Current Medical Research and Opinion
|
March 13, 2020
Systematic literature review of the global burden of illness of mantle cell lymphoma
Neerav Monga, Jamie Garside, Joan Quigley, et al.
American Journal of Hematology
|
December 20, 2021
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia
Matthew S Davids, Mazyar Shadman, Sameer A Parikh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2024
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy
Joshua Richter, Matthew S Davids, Colin Anderson-Smits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2015
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma
Jennifer R Brown, Matthew S Davids, Jordi Rodon, et al.
BJR Case Reports
|
October 27, 2018
Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple
Ann C Raldow, Johann G Brown, Nicole Chau, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 224) with videos related to
Sort By:
Page
of 23
Haematologica
|
May 30, 2024
The phase III DUO trial of PI3K inhibitor duvelisib <i>versus</i> ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival
Alexey V Danilov, Ian W Flinn, Matthew S Davids, et al.
European Journal of Heart Failure
|
May 10, 2017
Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia
David D Berg, Muthiah Vaduganathan, Anju Nohria, et al.
Pharmacoeconomics - Open
|
September 30, 2020
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
Neerav Monga, Jamie Garside, Matthew S Davids, et al.
Advances in Hematology
|
December 29, 2025
Multiple Myeloma and Secondary Immunodeficiency: A Retrospective Database Analysis Assessing Burden of Infection and Treatment Patterns
Csaba Siffel, Matthew S Davids, Colin Anderson-Smits, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States
Anuja Chatterjee, Sheila Shapouri, Beenish S Manzoor, et al.
Current Medical Research and Opinion
|
March 13, 2020
Systematic literature review of the global burden of illness of mantle cell lymphoma
Neerav Monga, Jamie Garside, Joan Quigley, et al.
American Journal of Hematology
|
December 20, 2021
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia
Matthew S Davids, Mazyar Shadman, Sameer A Parikh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 11, 2024
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy
Joshua Richter, Matthew S Davids, Colin Anderson-Smits, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2015
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory Lymphoma
Jennifer R Brown, Matthew S Davids, Jordi Rodon, et al.
BJR Case Reports
|
October 27, 2018
Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple
Ann C Raldow, Johann G Brown, Nicole Chau, et al.
Page
of 23